Disruption of mutated BRAF signaling modulates thyroid cancer phenotype

BACKGROUND: Thyroid cancer is the most common endocrine-related cancer in the United States and its incidence is rising rapidly. Since among various genetic lesions identified in thyroid cancer, the BRAFV600E mutation is found in 50% of papillary thyroid cancers and 25% of anaplastic thyroid cancers...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hanly, Elyse K, Rajoria, Shilpi, Darzynkiewicz, Zbigniew, Zhao, Hong, Suriano, Robert, Tuli, Neha, George, Andrea L, Bednarczyk, Robert, Shin, Edward J, Geliebter, Jan, Tiwari, Raj K
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3976539/
https://ncbi.nlm.nih.gov/pubmed/24673746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-7-187
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky